Next 10 |
BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S. markets open on Tuesday, May 7, 2024...
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa PR Newswire Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa BOSTON and ROLLE, Switzerland , April 23, 2024 /PRN...
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD) PR Newswire European-based Unilabs has deployed the SOPHiA DDM™ Platform across its network in Switzerland to support cancer diagnostics and treatment ...
2024-04-04 02:31:26 ET More on SOPHiA Genetics Sophia Genetics: Breakthrough Potential In A Cautious Healthcare Sector SOPHiA Genetics misses top-line and bottom-line estimates; initiates FY24 outlook Seeking Alpha’s Quant Rating on SOPHiA Genetics His...
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership Canada NewsWire The companies will join forces to advance the use of precision medicine on a global scale BOSTON and ROLLE, Switzerland , April 4, 2024 /CNW/ -- SOPHiA GE...
Laboratorio Barnafi-Krause is Live on SOPHiA DDM™ PR Newswire The Chile -based Laboratory is using SOPHiA GENETICS' platform to advance its research capabilities with blood disorders BOSTON and ROLLE, Switzerland , April 2, 2024 /PRNew...
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada PR Newswire University of Saskatchewan's (USask) Advanced Diagnostics Research Laboratory will use SOPHiA DDM™ Platform to advance research on ovarian cancer care ...
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration Canada NewsWire New Multimodal Algorithm Highlights Predictive Benefit Of Artificial Intelligence (AI) for Cancer Research BOSTON and ROLLE, Switzerlan...
BOSTON and ROLLE, Switzerland, March 07, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, today announced Chief Financial Officer and Chief Operating Officer, Ross Muken, will participate in a fireside chat at the Barcl...
2024-03-05 16:42:18 ET Gainers: Ebang International Holdings ( EBON ) +17% . CrowdStrike Holdings ( CRWD ) +17% . Couchbase ( BASE ) +14% . SOPHiA GENETICS ( SOPH ) +6% . Expensify ( EXFY ) +5% . Losers: ODDITY Tech...
News, Short Squeeze, Breakout and More Instantly...
SOPHiA GENETICS SA Company Name:
SOPH Stock Symbol:
NASDAQ Market:
BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven m...
BOSTON and ROLLE, Switzerland, April 23, 2024 (GLOBE NEWSWIRE) -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced it will release its financial results for the first quarter of fiscal year 2024 before U.S. markets open on Tuesday, May 7, 2024...
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa PR Newswire Syndicate Bio to implement new liquid biopsy offering to advance cancer diagnostics throughout Africa BOSTON and ROLLE, Switzerland , April 23, 2024 /PRN...